Clinical Trial Update: Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update investigating the use of SGLT2 inhibitors to improve myocardial perfusion and symptoms in women with angina due to nonobstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Microvascular Disease
• Coronary Microvascular Dysfunction
• Nonobstructive Coronary Artery Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Virginia | Conditions: Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease | Phase 1 | Status: RECRUITING